Collagenase, Type 5, 0.22u Filtered Reference: 252-10123 Collagenase Type 5, which is filtered through a 0.22 micron membrane and lyophilized in vials.
JGB1741 Reference: 10641-5 A SIRT1-specific inhibitor (IC50 = 15 μM); inhibits metastatic breast cancer MDA-MB 231 cell proliferation (IC50 = 512 nM), dose-dependently increasing p53 acetylation and p53-mediated apoptosis in these cells
Collagenase, Type 6 Reference: 252-10124 Prepared to contain high collagenase activity with a caseinase to collagenase ratio of ∼2:1. Designed to be enriched for Type II (col H) collagenase relative to Type I (col G). A dialyzed, lyophilized powder.
CAY10640 Reference: 10642-1 Inhibits recombinant human and mouse sEH (IC50s both = 0.4 nM) and demonstrates a 1,000-fold increase in potency compared to morphine in reducing hyperalgesia in an in vivo carrageenan-induced inflammatory pain model
Collagenase, Type 7 Reference: 252-10125 Prepared to contain collagenase and caseinase activities approximately four-fold higher than collagenase Types 1/2. A dialyzed, lyophilized powder.
CAY10640 Reference: 10642-10 Inhibits recombinant human and mouse sEH (IC50s both = 0.4 nM) and demonstrates a 1,000-fold increase in potency compared to morphine in reducing hyperalgesia in an in vivo carrageenan-induced inflammatory pain model